Australia's most trusted
source of pharma news
Monday, 16 September 2024
Posted 11 May 2023 AM
Novavax is slashing its global workforce, but is staying put in Australia.
In its first quarter 2023 financial results Novavax outlined plans to dramatically cut costs to stop its fiscal bleeding, including cutting a quarter of its workforce globally. However, its Director of Medical Affairs ANZ, Darrin Gilchrist, appointed just last year, will retain his position.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.